124 related articles for article (PubMed ID: 29205121)
1. Synthesis and Structure-Activity Relationship; Exploration of some Potent Anti-Cancer Phenyl Amidrazone Derivatives.
Habashneh AY; El-Abadelah MM; Bardaweel SK; Taha MO
Med Chem; 2018; 14(5):468-477. PubMed ID: 29205121
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activities of some new N1-(flavon-6-yl)amidrazone derivatives.
Habashneh AY; El-Abadelah MM; Zihlif MA; Imraish A; Taha MO
Arch Pharm (Weinheim); 2014 Jun; 347(6):415-22. PubMed ID: 24615985
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological activity of phenyl-pyrazole derivatives as BCR-ABL kinase inhibitors.
Hu L; Zheng Y; Li Z; Wang Y; Lv Y; Qin X; Zeng C
Bioorg Med Chem; 2015 Jul; 23(13):3147-52. PubMed ID: 26022079
[TBL] [Abstract][Full Text] [Related]
4. 2-Benzoylbenzofuran derivatives possessing piperazine linker as anticancer agents.
Gao H; Zhang X; Pu XJ; Zheng X; Liu B; Rao GX; Wan CP; Mao ZW
Bioorg Med Chem Lett; 2019 Mar; 29(6):806-810. PubMed ID: 30709651
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents.
Alam MS; Lee DU
Arch Pharm Res; 2016 Feb; 39(2):191-201. PubMed ID: 26694484
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as Potential Antileukemic Agents.
Dolatkhah Z; Javanshir S; Sadr AS; Hosseini J; Sardari S
J Chem Inf Model; 2017 Jun; 57(6):1246-1257. PubMed ID: 28524659
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel Bcr-Abl inhibitors with diacylated piperazine as the flexible linker.
Pan X; Dong J; Shi Y; Shao R; Wei F; Wang J; Zhang J
Org Biomol Chem; 2015 Jul; 13(25):7050-66. PubMed ID: 26052668
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and anticancer activity of novel hybrid compounds between benzofuran and N-aryl piperazine.
Mao ZW; Zheng X; Lin YP; Hu CY; Wang XL; Wan CP; Rao GX
Bioorg Med Chem Lett; 2016 Aug; 26(15):3421-4. PubMed ID: 27371110
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, anticancer, and docking studies of salicyl-hydrazone analogues: A novel series of small potent tropomyosin receptor kinase A inhibitors.
Alam MS; Choi SU; Lee DU
Bioorg Med Chem; 2017 Jan; 25(1):389-396. PubMed ID: 27856237
[TBL] [Abstract][Full Text] [Related]
10. New palbociclib analogues modified at the terminal piperazine ring and their anticancer activities.
Wang P; Huang J; Wang K; Gu Y
Eur J Med Chem; 2016 Oct; 122():546-556. PubMed ID: 27448913
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Biopharmaceutical Evaluation of Imatinib Analogues Featuring Unusual Structural Motifs.
Nicolaou KC; Vourloumis D; Totokotsopoulos S; Papakyriakou A; Karsunky H; Fernando H; Gavrilyuk J; Webb D; Stepan AF
ChemMedChem; 2016 Jan; 11(1):31-7. PubMed ID: 26585829
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity assays of some new N1-(flavon-7-yl)amidrazone derivatives and related congeners.
Abu-Aisheh MN; Mustafa MS; El-Abadelah MM; Naffa RG; Ismail SI; Zihlif MA; Taha MO; Mubarak MS
Eur J Med Chem; 2012 Aug; 54():65-74. PubMed ID: 22677031
[TBL] [Abstract][Full Text] [Related]
13. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells.
Dandawate P; Ahmad A; Deshpande J; Swamy KV; Khan EM; Khetmalas M; Padhye S; Sarkar F
Bioorg Med Chem Lett; 2014 Jul; 24(13):2900-4. PubMed ID: 24835626
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiproliferative evaluation of piperazine-1-carbothiohydrazide derivatives of indolin-2-one.
Lin HH; Wu WY; Cao SL; Liao J; Ma L; Gao M; Li ZF; Xu X
Bioorg Med Chem Lett; 2013 Jun; 23(11):3304-7. PubMed ID: 23602441
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of Dihydrazones as Potential Anticancer and DNA Binding Candidates: A Validation by Molecular Docking Studies.
Sridhara MB; Rakesh KP; Manukumar HM; Shantharam CS; Vivek HK; Kumara HK; Mohammed YHE; Gowda DC
Anticancer Agents Med Chem; 2020; 20(7):845-858. PubMed ID: 32096753
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and bioevaluation and doking study of 1H-pyrrolo[2,3-b]pyridine derivatives bearing aromatic hydrazone moiety as c-Met inhibitors.
Wang W; Xu S; Duan Y; Liu X; Li X; Wang C; Zhao B; Zheng P; Zhu W
Eur J Med Chem; 2018 Feb; 145():315-327. PubMed ID: 29331754
[TBL] [Abstract][Full Text] [Related]
17. Analogue-based design, synthesis and biological evaluation of 3-substituted-(methylenehydrazono)indolin-2-ones as anticancer agents.
Dweedar HE; Mahrous H; Ibrahim HS; Abdel-Aziz HA
Eur J Med Chem; 2014 May; 78():275-80. PubMed ID: 24686014
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization, molecular modeling, and potential antimicrobial and anticancer activities of novel 2-aminoisoindoline-1,3-dione derivatives.
Ahmed HE; Abdel-Salam HA; Shaker MA
Bioorg Chem; 2016 Jun; 66():1-11. PubMed ID: 26986635
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interactions between DMAG and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylate.
Nguyen TK; Rahmani M; Gao N; Kramer L; Corbin AS; Druker BJ; Dent P; Grant S
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2239-47. PubMed ID: 16609040
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro and in vivo evaluation of novel substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines as potent antitumor agents.
Cao D; Wang X; Lei L; Ma L; Wang F; Wang C; Tang M; Xiang W; Wang T; Li H; Chen L
Bioorg Med Chem Lett; 2016 Apr; 26(8):1931-5. PubMed ID: 26979159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
